“Harnessing Immune Checkpoint Inhibitors Against Gastric Cancer: Charting the Course to Expanded Therapeutic Benefit” (2024) Biomedical Research and Therapy, 11(4), pp. 6305–6325. doi:10.15419/bmrat.v11i4.877.